A NOVEL CD147 INHIBITOR SP-8356 ATTENUATES PLAQUE PROGRESSION AND STABILIZES VULNERABLE PLAQUE IN APOE-DEFICIENT MICE
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pahk, K. | - |
dc.contributor.author | Joung, C. | - |
dc.contributor.author | Song, H. Y. | - |
dc.contributor.author | Kim, S. | - |
dc.contributor.author | Kim, W. | - |
dc.date.accessioned | 2021-09-01T13:34:45Z | - |
dc.date.available | 2021-09-01T13:34:45Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2019-07 | - |
dc.identifier.issn | 0263-6352 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/64704 | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.title | A NOVEL CD147 INHIBITOR SP-8356 ATTENUATES PLAQUE PROGRESSION AND STABILIZES VULNERABLE PLAQUE IN APOE-DEFICIENT MICE | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, S. | - |
dc.identifier.doi | 10.1097/01.hjh.0000571364.28568.f9 | - |
dc.identifier.wosid | 000481429700279 | - |
dc.identifier.bibliographicCitation | JOURNAL OF HYPERTENSION, v.37, pp.E105 - E106 | - |
dc.relation.isPartOf | JOURNAL OF HYPERTENSION | - |
dc.citation.title | JOURNAL OF HYPERTENSION | - |
dc.citation.volume | 37 | - |
dc.citation.startPage | E105 | - |
dc.citation.endPage | E106 | - |
dc.type.rims | ART | - |
dc.type.docType | Meeting Abstract | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Peripheral Vascular Disease | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.